scispace - formally typeset
S

Sharleen Imes

Researcher at University of Alberta

Publications -  34
Citations -  3355

Sharleen Imes is an academic researcher from University of Alberta. The author has contributed to research in topics: Transplantation & Islet. The author has an hindex of 19, co-authored 31 publications receiving 3191 citations. Previous affiliations of Sharleen Imes include Alberta Health Services & University of Alberta Hospital.

Papers
More filters
Journal ArticleDOI

Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol

TL;DR: Islet transplantation has successfully corrected labile type 1 diabetes and problems with hypoglycemia, and the results show persistent insulin secretion, which is consistent with good glycemic control.
Journal ArticleDOI

Successful islet transplantation: continued insulin reserve provides long-term glycemic control.

TL;DR: The results indicate that prolonged insulin independence can be achieved after islet transplantation, and there are some risks associated acutely with the procedure, and hypercholesterolemia and hypertension are treatable concerns on longer-term follow-up.
Journal ArticleDOI

Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes

TL;DR: These results demonstrate that in newly diagnosed type 2 diabetes with elevated fasting glucose levels, a 2- to 3-week course of intensive insulin therapy can successfully lay a foundation for prolonged good glycemic control.
Journal ArticleDOI

Islet Graft Assessment in the Edmonton Protocol: Implications for Predicting Long-Term Clinical Outcome

TL;DR: T careful assessment of islet graft composition is needed in a clinical transplantation program to accurately estimate islet purity and assess the contribution of other cell types present, such as islet progenitor cells.
Journal ArticleDOI

Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes

TL;DR: It is concluded that Ultradian insulin secretory oscillations during constant glucose infusion are normal in women with a history of GDM, and defects in insulin secretion and action in post-GDM subjects who are at high risk for the development of NIDDM are found.